(NASDAQ: OMER) Omeros's forecast annual revenue growth rate of 102.78% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 32.77%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.78%.
Omeros's revenue in 2026 is $38,422,000.On average, 6 Wall Street analysts forecast OMER's revenue for 2026 to be $9,273,667,163, with the lowest OMER revenue forecast at $7,314,115,449, and the highest OMER revenue forecast at $11,051,524,204. On average, 5 Wall Street analysts forecast OMER's revenue for 2027 to be $15,892,130,895, with the lowest OMER revenue forecast at $13,564,122,652, and the highest OMER revenue forecast at $19,457,979,341.
In 2028, OMER is forecast to generate $23,330,030,364 in revenue, with the lowest revenue forecast at $16,607,327,457 and the highest revenue forecast at $28,198,868,498.